IP Library Granted Patent US 9,598,532
Granted Patent B2
US 9,598,532 · App. 13/221,389 · Granted Mar 21, 2017

Terpolymers as pressure-sensitive adhesives

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,598,532
App. No.
13/221,389
Granted
Mar 21, 2017
Kind
B2
Abstract

Disclosed herein are terpolymers that can function as pressure-sensitive adhesives. The disclosed articles comprise the terpolymers adhered to a release liner. The disclosed implant devices comprise the pressure-sensitive adhesive terpolymer adhered to a surface thereof. The pressure-sensitive adhesive terpolymer can promote adhesion of the implant device to a location in a subject.

Claims (11)

1. An article, comprising:

a pressure-sensitive adhesive (PSA) having a first adhesive surface and an opposing second adhesive surface,

the pressure-sensitive adhesive (PSA) comprises a poly(D,L-lactide-co-glycolide-co-ε-caprolactone) having a molecular weight (M w ) of from 100,000 to 140,000 Daltons and a polydispersity index (PDI) of less than 2.0;

wherein the poly(D,L-lactide-co-glycolide-co-ε-caprolactone) exhibits storage modulus (G′) values of from about 1.5×10 5 Pa to about 5.5×10 5 Pa, over a frequency of from about 0.1 to about 1 Hz; and

exhibits storage modulus (G′) values of from about 1.0×10 6 Pa to about 4.0×10 6 Pa, over a frequency of from about 10 2 to about 10 4 Hz at 30° C.;

the poly(D,L-lactide-co-glycolide-co-ε-caprolactone) comprising from 50 to 60 mol % caprolactone; and

a bioactive agent selected from the group consisting of gentamicin, tobramycin, rifampin, and minocycline, or combinations thereof; and

a release liner, wherein the release liner fully covers the first adhesive surface and the second adhesive surface of the pressure-sensitive adhesive.

2. The article of claim 1 , wherein the pressure-sensitive adhesive (PSA) consists of the poly(D,L-lactide-co-glycolide-co-ε-caprolactone).

3. The article of claim 1 , the pressure-sensitive adhesive comprising a planar film.

4. The article of claim 1 , wherein the pressure-sensitive adhesive is divided into a plurality of discrete units separated from one another, the plurality of units held together by the release liner.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 8, 2025
From: SURMODICS, INC.
To: SURMODICS MD, LLC
Reel/Frame 073894/0058 →
RELEASE OF SECURITY INTEREST Recorded Nov 24, 2025
From: MIDCAP FUNDING IV TRUST
To: SURMODICS, INC.; SURMODICS SHARED SERVICES, LLC; SURMODICS HOLDINGS, LLC; SURMODICS COATINGS, LLC; SURMODICS MD, LLC; SURMODICS COATINGS MFG, LLC; SURMODICS IVD, INC.; SURMODICS MD OPERATIONS, LLC; NORMEDIX, INC.
Reel/Frame 073690/0186 →
SECURITY INTEREST Recorded Aug 23, 2024
From: SURMODICS, INC.; SURMODICS SHARED SERVICES, LLC; SURMODICS HOLDINGS, LLC; SURMODICS COATINGS, LLC; SURMODICS MD, LLC; SURMODICS COATINGS MFG, LLC; SURMODICS IVD, INC.; SURMODICS MD OPERATIONS, LLC; NORMEDIX, INC.
To: MIDCAP FUNDING IV TRUST
Reel/Frame 068762/0423 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 19, 2011
From: BOWMAN, HOWARD; HUDSON, BRUCE W.
To: SURMODICS PHARMACEUTICALS, INC.
Reel/Frame 027411/0452 →